Carolinas Wealth Consulting LLC Novartis Ag Transaction History
Carolinas Wealth Consulting LLC
- $535 Million
- Q1 2024
A detailed history of Carolinas Wealth Consulting LLC transactions in Novartis Ag stock. As of the latest transaction made, Carolinas Wealth Consulting LLC holds 214 shares of NVS stock, worth $23,139. This represents 0.0% of its overall portfolio holdings.
Number of Shares
214
Previous 176
21.59%
Holding current value
$23,139
Previous $17,000
17.65%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding NVS
# of Institutions
1,350Shares Held
140MCall Options Held
1.15MPut Options Held
866K-
Primecap Management CO Pasadena, CA12.4MShares$1.34 Billion0.91% of portfolio
-
Dodge & Cox San Francisco, CA12.4MShares$1.34 Billion0.73% of portfolio
-
Morgan Stanley New York, NY7.26MShares$785 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX6.02MShares$651 Million0.16% of portfolio
-
Loomis Sayles & CO L P5.92MShares$640 Million0.81% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $233B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...